ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

Clinical trial NCT06838676 · RECRUITING

Trial details

NCT number: NCT06838676
Sponsor: Nationwide Children's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Gliomas (DIPG)Progressive DIPG Refractory DIPG Recurrent DIPG H3K27-altered High Grade Glioma

Start date: 2025-07-10
Primary completion: 2028-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.